Track the 株式会社PRISM BioLab share price and the full insider trade history of the company, a listed issuer based in Japan. Shares are listed on the JP market, under the oversight of EDINET (Japan FSA). Market capitalisation: €6.2bn. The latest transaction was disclosed on 6 August 2026 (Holding update). Among the most active insiders: WM PARTNERS Co., Ltd.. Every trade is accessible without an account.
18
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
n/a
Sell Volume
27Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 25,927 of 28,985 companies
22.4
score / 100
Value
11
Quality
33
FCF yld-23%
Earn yld-12%
EV/EBITDA·
ROE-38%
Gross mgn40%
Net mgn·
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
PRISM BioLab is a Japanese company listed on the XTKS market, specializing in the development of biopharmaceutical solutions. It focuses on innovation in the biotechnology sector.